Houston Methodist welcomes oncologist Andrew Johnsrud, M.D

September 21, 20222 min

Houston Methodist Sugar Land Hospital is pleased to welcome board-certified hematologist-oncologist Andrew Johnsrud, M.D., to Houston Methodist Oncology Partners at Sugar Land.

 

Johnsrud is a graduate of the University of Texas Medical Branch in Galveston, Texas. He completed his residency in internal medicine at the University of Arkansas for Medical Sciences. Following his residency, Johnsrud completed a hematology-oncology fellowship at the University of Arkansas for Medical Sciences and a blood and marrow transplantation/cellular therapy fellowship at Stanford University. He recently completed a postdoctoral fellowship in blood and marrow transplantation/cellular therapy at Stanford University.

 

“I am excited to join Houston Methodist Oncology Partners at Sugar Land,” said Johnsrud. “My goal is to provide state-of-the-art care for each patient, using a comprehensive approach tailored to the needs of individuals and their families. At Houston Methodist, we will work together to provide the best available care to achieve optimal long-term outcomes for patients.”

 

Johnsrud joins Patrick Prath, M.D., Sindhu Nair, M.D., and Kirtan Nautiyal, M.D., where he will care for hematology and oncology patients.

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives